Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier for longer.

Game-changing diabetes pills could hit Australian shelves within years, offering an alternative to popular injectable ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...

The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year, ending in April, up 10.7% from the prior year. Medtronic reported more than $34 billion in sales last year.

These days, more and more of us have to worry about our blood sugar. Some 38 million Americans have diabetes, and more than two times that number have pre-diabetes.Many millions more have some ...

Diabetes can affect how the body manages temperature and may cause some people to sweat more or less. This can include night sweats, sweating while eating, or sweating when it’s cool. Treatment ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 diabetes lose an average of nearly 8% of their body weight after 40 weeks ...

Michelle Trachtenberg died from diabetes complications at 39. The condition is called the “silent killer" and can develop after an organ transplant, an expert tells PEOPLE.

Death rates from diabetes peaked in 2021, according to CDC figures, at 31.1 deaths per 100,000 people for that year. Diabetes was the eighth leading cause of death in 2021.

Joel Snitman, 81, of Thornhill, Ont., has Type 2 diabetes and says he trusted an ad for a blood glucose testing product he saw on Facebook because it had Diabetes Canada's logo. However, Diabetes ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.